[96a5a0]: / output / allTrials / identified / NCT00359476_identified.json

Download this file

369 lines (369 with data), 15.5 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
{
"info": {
"nct_id": "NCT00359476",
"official_title": "A Multicenter, Single-Arm, Phase II Study of Single-Agent Vinflunine in the Second-line Treatment of Patients With Gastric Cancer",
"inclusion_criteria": "* Patients with locally advanced or metastatic gastric adenocarcinoma, including adenocarcinoma of the gastroesophageal junction who have progressed on a fluoropyrimidine or taxane-containing regimen in any combination in one prior first line treatment.\n* EGOC performance status of 0,1 or 2\n* Men and women, 18 years of age and older\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Patients having received more than one previous systemic chemotherapy regimen in any setting.\n* Major abdominal surgery within 2 months or any other surgery under general anesthesia within 4 weeks\n* Unresolved occlusive or sub-occlusive intestinal disease or any significant chronic intestinal disease (e.g. ulcerative colitis)\n* Prior radiation to >=30% of the bone marrow and/or radiation within 4 weeks prior to enrollment\n* Acute or chronic hepatitis\n* Known HIV infection\n* A marked baseline prolongation of QT/QTc interval (e.g., repeated demonstration of a QTc interval >450 ms\n* A history of additional risk factors for Torsade de Pointes (e.g., heart failure hypokalemia, family history of Long QT Syndrome)",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Patients with locally advanced or metastatic gastric adenocarcinoma, including adenocarcinoma of the gastroesophageal junction who have progressed on a fluoropyrimidine or taxane-containing regimen in any combination in one prior first line treatment.",
"criterions": [
{
"exact_snippets": "locally advanced or metastatic gastric adenocarcinoma",
"criterion": "gastric adenocarcinoma",
"requirements": [
{
"requirement_type": "stage",
"expected_value": [
"locally advanced",
"metastatic"
]
}
]
},
{
"exact_snippets": "adenocarcinoma of the gastroesophageal junction",
"criterion": "adenocarcinoma of the gastroesophageal junction",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "progressed on a fluoropyrimidine or taxane-containing regimen",
"criterion": "progression on fluoropyrimidine or taxane-containing regimen",
"requirements": [
{
"requirement_type": "progression",
"expected_value": true
}
]
},
{
"exact_snippets": "one prior first line treatment",
"criterion": "prior first line treatment",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": "=",
"value": 1,
"unit": "prior first line treatment"
}
}
]
}
]
},
{
"line": "* EGOC performance status of 0,1 or 2",
"criterions": [
{
"exact_snippets": "EGOC performance status of 0,1 or 2",
"criterion": "EGOC performance status",
"requirements": [
{
"requirement_type": "value",
"expected_value": [
"0",
"1",
"2"
]
}
]
}
]
},
{
"line": "* Men and women, 18 years of age and older",
"criterions": [
{
"exact_snippets": "Men and women",
"criterion": "gender",
"requirements": [
{
"requirement_type": "allowed_values",
"expected_value": [
"male",
"female"
]
}
]
},
{
"exact_snippets": "18 years of age and older",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Patients having received more than one previous systemic chemotherapy regimen in any setting.",
"criterions": [
{
"exact_snippets": "Patients having received more than one previous systemic chemotherapy regimen",
"criterion": "previous systemic chemotherapy regimens",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">",
"value": 1,
"unit": "regimen"
}
}
]
}
]
},
{
"line": "* Major abdominal surgery within 2 months or any other surgery under general anesthesia within 4 weeks",
"criterions": [
{
"exact_snippets": "Major abdominal surgery within 2 months",
"criterion": "major abdominal surgery",
"requirements": [
{
"requirement_type": "time since surgery",
"expected_value": {
"operator": "<=",
"value": 2,
"unit": "months"
}
}
]
},
{
"exact_snippets": "any other surgery under general anesthesia within 4 weeks",
"criterion": "surgery under general anesthesia",
"requirements": [
{
"requirement_type": "time since surgery",
"expected_value": {
"operator": "<=",
"value": 4,
"unit": "weeks"
}
}
]
}
]
},
{
"line": "* Unresolved occlusive or sub-occlusive intestinal disease or any significant chronic intestinal disease (e.g. ulcerative colitis)",
"criterions": [
{
"exact_snippets": "Unresolved occlusive or sub-occlusive intestinal disease",
"criterion": "occlusive or sub-occlusive intestinal disease",
"requirements": [
{
"requirement_type": "resolution",
"expected_value": false
}
]
},
{
"exact_snippets": "any significant chronic intestinal disease (e.g. ulcerative colitis)",
"criterion": "chronic intestinal disease",
"requirements": [
{
"requirement_type": "significance",
"expected_value": "significant"
}
]
}
]
},
{
"line": "* Prior radiation to >=30% of the bone marrow and/or radiation within 4 weeks prior to enrollment",
"criterions": [
{
"exact_snippets": "Prior radiation to >=30% of the bone marrow",
"criterion": "radiation to bone marrow",
"requirements": [
{
"requirement_type": "extent",
"expected_value": {
"operator": ">=",
"value": 30,
"unit": "%"
}
},
{
"requirement_type": "prior",
"expected_value": true
}
]
},
{
"exact_snippets": "radiation within 4 weeks prior to enrollment",
"criterion": "radiation",
"requirements": [
{
"requirement_type": "time frame",
"expected_value": "within 4 weeks prior to enrollment"
}
]
}
]
},
{
"line": "* Acute or chronic hepatitis",
"criterions": [
{
"exact_snippets": "Acute or chronic hepatitis",
"criterion": "hepatitis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
},
{
"requirement_type": "type",
"expected_value": [
"acute",
"chronic"
]
}
]
}
]
},
{
"line": "* Known HIV infection",
"criterions": [
{
"exact_snippets": "Known HIV infection",
"criterion": "HIV infection",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* A marked baseline prolongation of QT/QTc interval (e.g., repeated demonstration of a QTc interval >450 ms",
"criterions": [
{
"exact_snippets": "baseline prolongation of QT/QTc interval ... QTc interval >450 ms",
"criterion": "QT/QTc interval",
"requirements": [
{
"requirement_type": "prolongation",
"expected_value": true
},
{
"requirement_type": "length",
"expected_value": {
"operator": ">",
"value": 450,
"unit": "ms"
}
}
]
}
]
},
{
"line": "* A history of additional risk factors for Torsade de Pointes (e.g., heart failure hypokalemia, family history of Long QT Syndrome)",
"criterions": [
{
"exact_snippets": "A history of additional risk factors for Torsade de Pointes",
"criterion": "risk factors for Torsade de Pointes",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "heart failure",
"criterion": "heart failure",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "hypokalemia",
"criterion": "hypokalemia",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "family history of Long QT Syndrome",
"criterion": "family history of Long QT Syndrome",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}